Nominated as Technology Company of the Year in Celebration of Achievement and Innovation for Life Sciences Leaders Horsham, Pa.; May 25, 2022 — Clinical ink, …
Clinical ink Nominated for 2022 PACT Enterprise Awards Read More…
85% accuracy in early Parkinson’s classification establishes Clinical ink as the industry leader in patient science and digital biomarkers Cutting-edge research reveals greater insights into …
Cutting-edge research reveals greater insights into Parkinson’s Disease progression Read More…
JAMA publication demonstrates assessment validity, points to future research and real-world applications Horsham, Pa.; February 16, 2022 — Clinical ink, a global clinical technology company, …
Clinical ink’s technology deployed for groundbreaking cannabis research Read More…
Attributes 293% Revenue Growth to technologies that simplify and accelerate complex clinical trial activities HORSHAM, Pa.; Nov. 17, 2021 (Business Wire) – Clinical Ink today …
HORSHAM, Pa.; Nov. 8, 2021 –
Horsham, Pa.; August 12, 2021 – Clinical Ink, a global clinical trial technology company, today announced that CBO Jonathan Andrus has been selected to co-lead …
New Role to Serve Rapidly Expanding Global Customer Base Horsham, Pa.; May 18, 2021 – Clinical Ink, a global clinical trial technology company, today announced …
Clinical Ink Hires Industry Veteran Janette Morgan as General Manager, EMEA Read More…
New Positions Created to Manage Dramatic Growth HORSHAM, Pa.; May 4, 2021 – Clinical Ink, a global clinical trial technology company, today announced the hiring …
Clinical Ink Hires CCO Chris Crucitti, COO Brian Donahue, VP Bill Barrasso Read More…
HORSHAM, Pa.; April 20, 2021 – Clinical Ink, a global clinical trial technology company, today announced it has deployed an industry-leading 500 unique eCOA scales …
HORSHAM, Pa.; April 6, 2021 – Clinical Ink, a global clinical trial technology company, today announced it has added its 16th concurrent Phase II/III Alzheimer’s …
Insert HTML text here.